Gene transfer vectors targeted to human prostate cancer: do we need better preclinical testing systems?

Human gene therapy

Volumn 21, Issue 7, 2010, Pages 815-827

  Maitland, Norman ^a   Chambers, Karen ^b   Georgopoulos, Lindsay ^b   Simpson Holley, Martha ^b   Leadley, Regina ^b   Evans, Helen ^b   Essand, Magnus ^b   Danielsson, Angelika ^b   van Weerden, Wytske ^b   de Ridder, Corrina ^b   Kraaij, Robert ^b   Bangma, Chris H ^b   GIANT FP6 Consortium, ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGICAL MODEL; CANCER STAGING; CLINICAL TRIAL; GENE THERAPY; GENE VECTOR; HUMAN; MALE; METHODOLOGY; PROSTATE TUMOR; REVIEW; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CLINICAL TRIALS AS TOPIC; GENE THERAPY; GENETIC VECTORS; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 77957958753     PISSN: None     EISSN: 15577422     Source Type: Journal    
DOI: 10.1089/hum.2009.210     Document Type: Review

References (92)